Inside Ethics: Pfizer Shows Risks of Unethical Marketing, by Ellen Leinfuss

publication date: Oct 29, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Pfizer’s eye-popping settlement with the DOJ raises questions about ethical marketing practices in the pharmaceutical and health care industry—and beyond. For E&C professionals, there are several lessons to be learned...


To view this you will need to become a member. 
Learn More and Become a Member!
Search by Topic
News & Events

Kaplan EduNeering is proud to announce the launch of our new website that affords visitors easy access to complimentary resources such as white papers, case studies and webinars.

Visit us today!!>>

Get the ECC Library!

Over 2,000 ethics communication and training tools, covering over 50 topics... Contact Us to Upgrade Your Subscription >>